Bottom line
LABU vs DRN: the short answer
LABU (Direxion Daily S&P Biotech Bull 3X ETF) and DRN (Direxion Daily Real Estate Bull 3X ETF) are quite different portfolios: only about 34% of their top holdings (by weight) are shared.
But LABU is far broader, holding 163 positions to 36 for DRN, so beyond the top names it adds exposure DRN doesn't have.
LABU is cheaper at 0.96% vs 0.98% — a difference of $2.00 a year per $10,000 invested.
Over five years, DRN returned −4.8% a year vs −39.6% for LABU.
Updated Nov 19, 2026
LABU vs DRN side by side
| LABU | DRN | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Direxion | Direxion |
| Category | Leveraged & Inverse | Leveraged & Inverse |
| Expense ratio | 0.96% | 0.98% |
| Annual cost per $10k | $96 | $98 |
| 10-yr cost on $10k (prospectus) | $1,178 | $1,201 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +78.7% | −11.5% |
| 5-yr return (annualized) | −39.6% | −4.8% |
| 10-yr return (annualized) | −20.8% | −5.4% |
| Best quarter | +161.5% | +56.7% |
| Worst quarter | −67.4% | −71.7% |
| Net assets (fund) | $494.4M | $45.0M |
| Number of holdings | 163 | 36 |
| Portfolio turnover | 107% | 15% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | LABU | DRN | Difference |
|---|---|---|---|
| 2025 | +78.7% | −11.5% | +90.2% |
| 2024 | −25.9% | −5.3% | −20.7% |
| 2023 | −13.4% | +11.9% | −25.4% |
| 2022 | −80.3% | −67.1% | −13.2% |
| 2021 | −64.3% | +153.3% | −217.6% |
| 2020 | +74.7% | −55.7% | +130.4% |
| 2019 | +74.6% | +82.0% | −7.4% |
| 2018 | −57.3% | −25.0% | −32.3% |
| 2017 | +148.7% | +7.7% | +141.0% |
| 2016 | −63.0% | +13.3% | −76.4% |
Source: Fund prospectus bar charts
Holdings overlap
6 of LABU's top 25 holdings also appear in DRN's top 25.
| Holding | LABU | DRN |
|---|---|---|
| Dreyfus | 15.86% | 22.57% |
| Goldman Financial | 14.83% | 8.78% |
| N/a | 9.63% | 7.33% |
| N/a | 7.30% | 7.33% |
| N/a | 4.85% | 7.33% |
| N/a | 3.87% | 7.33% |
Source: SEC Form N-PORT
LABU top 10
- Dreyfus — 15.86%
- Goldman Financial — 14.83%
- N/a — 9.63%
- N/a — 7.30%
- Goldman Sachs Liq Es Fd A — 5.35%
- N/a — 4.85%
- N/a — 3.87%
- Apogee Therapeutics Inc — 1.11%
- Oruka Therapeutics Inc — 1.03%
- Dianthus Therapeutics Inc — 0.96%
DRN top 10
- Dreyfus — 22.57%
- Goldman Financial — 8.78%
- N/a — 8.15%
- Welltower Inc — 7.82%
- N/a — 7.33%
- Prologis Inc — 6.37%
- Equinix Inc — 4.75%
- American Tower Corp — 3.82%
- Simon Property Group Inc — 3.52%
- Digital Realty Trust Inc — 3.45%
FAQ
What is the difference between LABU and DRN?
Which is cheaper, LABU or DRN?
Should I own both LABU and DRN?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.